Baxter International Inc (BAX) Buy, Sell or…

Home

Daily Stock Opinions and Ratings

Baxter International Inc (BAX)

19.38

+0.03 (0.16%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

11 watching

HOLD

Likes it but will not buy more right now. It’s Christine Pool’s stock.

PAST TOP PICK

(A Top Pick Aug 11/10. Up 33.66%.) Hospital supply company. Very big in the kidney dialysis market. Likes the demographics.

COMMENT

Well diversified healthcare company. Trades at a reasonable multiple. Yield of about 2.5%-3%. Always increases its dividend.

HOLD

Diversified health care. Had some obstacles in their bioscience division that they had to overcome last year. These are now being resolved. Trading at about 10X forward earnings. Good yield of 2.5%.

PAST TOP PICK

(A Top Pick Jan 11/10. Down 10.65%.)

PAST TOP PICK

(A Top Pick Nov 26/09. Down 7%.) Health care. Encountered some problems earlier this year in their plasma/protein market. Trading at an attractive multiple. Over 3% yield. Still a Hold.

PAST TOP PICK

(A Top Pick Nov 26/09. Down 4.37%.) Still likes.

PAST TOP PICK

(A Top Pick Oct 15/09. Down 10%.) Misjudged supply/demand situation so they had to reduce guidance to bring supply picture back in line. Conditions are stabilizing.

WAIT

Well run company. Excellent Fair Market Value if you can believe the forecasts. Medical index registered a Sell signal a little while ago for him. Doesn't think the bottom is too far away on this.

TOP PICK

Medical devices. About 60% of sales are outside of the US. Big in kidney dialysis, haemophilia, vaccines, and aesthetics, etc. Most of their growth is in developing countries.

BUY

Encountered some problems in their plasma protein business and there was excess supply. Looks like conditions have stabilized. Likes the long-term prospects. Attractive investment if you have a view longer than 1 year.

TOP PICK

Brand new holding – health care and he likes the long-term outlook to health care. It’s not a drug company and 60% of business is out of the country. Big overseas market developing. Stock got hit and that is the opportunity to buy it.

HOLD

Stock fell because profits were going to come off with increased rebates to Medicare. Company makes plasma protein products. Had to reduce guidance because of an oversupply of plasma. Also had to recall all their medical delivery pumps. Still has confidence in management.

TOP PICK

Diversified drug company. 60% of revenues from outside of North America. Good exposure to emerging countries. No concerns about products given the US healthcare reform. Consistently posts double-digit earnings growth. Strong balance sheet. Buys back stock with excess cash flow. Good pipeline going forward. 2% yield.

TOP PICK

Diverse healthcare company. Focuses on blood and circulatory systems. Margins have been improving. Shutting down inefficient operations. Good product pipeline going forward. Strong cash flow. 60% of revenues are outside of the US.

Showing 16 to 30 of 35 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Baxter International Inc (BAX)